Janux Therapeutics JANX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$24.36M+23.7% | -$31.95M-31.4% | -$24.31M+28.2% | -$33.86M-44.0% | -$23.51M-16.3% | ||
| $469K+0.2% | $468K-6.6% | $501K-7.4% | $541K+4.2% | $519K+1.4% | ||
| $9.27M-2.6% | $9.52M+5.2% | $9.04M-17.5% | $10.96M+2.4% | $10.7M+71.2% | ||
| -$12.34M+56.8% | -$28.54M-122% | -$12.86M+46.0% | -$23.81M-39.9% | -$17.02M-1.8% | ||
| $273K+158% | $106K+14.0% | $93K-80.3% | $473K+27.5% | $371K+783% | ||
| $8.29M— | —— | —— | —— | -$340.39M— | ||
| $3.55M+20.4% | $2.94M+497% | $493K-48.3% | $954K+72.2% | $554K-99.9% | ||
| -$506K— | $0+100% | -$4.06M+81.0% | -$21.3M+94.0% | -$356.86M-188% | ||
| -$12.61M+56.0% | -$28.65M-121% | -$12.95M+46.7% | -$24.29M-39.6% | -$17.4M-3.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Janux Therapeutics generate?
- Janux Therapeutics (JANX) generated -$77.5M in operating cash flow over the trailing twelve months.
- What is Janux Therapeutics's free cash flow?
- After $945.0K of capital expenditures, Janux Therapeutics's free cash flow was -$78.5M over the trailing twelve months, down 68.7% year over year.
- Where does Janux Therapeutics's cash flow data come from?
- Every line is extracted from Janux Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
